Adimmune Corporation (TPE:4142)

Adimmune Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,029	2,345	2,458	2,857	2,652	4,087
Short-Term Investments	112.5	112.5	12.5	100.5	239	337.06
Cash & Short-Term Investments	2,141	2,457	2,470	2,958	2,891	4,425
Cash Growth	-28.42%	-0.52%	-16.49%	2.30%	-34.66%	302.92%
Accounts Receivable	184.77	187.81	1,308	534.97	99.64	109.75
Other Receivables	33.48	39.76	30.51	43.09	111.22	5.73
Receivables	218.25	227.57	1,339	578.06	210.86	115.48
Inventory	818.51	764.59	682.33	815.94	602.1	302.05
Prepaid Expenses	5.73	6.45	8.19	4.42	4	165.46
Other Current Assets	163.47	154.27	200.21	135.34	88.02	39.07
Total Current Assets	3,347	3,610	4,699	4,491	3,796	5,047
Property, Plant & Equipment	3,876	3,818	3,613	3,641	3,447	2,352
Long-Term Investments	101.3	109.66	105.86	100.25	119.34	137.08
Other Intangible Assets	30.44	34.46	51.11	67.98	85.82	101.69
Long-Term Accounts Receivable	334.93	334.93	334.93	326.66	137.37	-
Long-Term Deferred Tax Assets	227.42	227.42	227.6	227.59	228.03	227.89
Long-Term Deferred Charges	11.91	13.4	19.36	25.32	31.27	37.23
Other Long-Term Assets	401.08	333.93	433.57	268.29	165.53	570.66
Total Assets	8,330	8,481	9,484	9,149	8,010	8,473
Accounts Payable	50.04	31.25	42.35	48.84	5.88	23.46
Accrued Expenses	159.13	164.26	126.85	192.83	145.77	120.11
Short-Term Debt	400	500	540	20	-	-
Current Portion of Long-Term Debt	523.17	320.04	669.93	125.01	41.09	2.07
Current Portion of Leases	22.6	19.02	14.71	16.68	7.13	7.23
Current Unearned Revenue	68.67	9.39	21.81	11.11	23.44	167.91
Other Current Liabilities	36.76	117.35	371.3	86.02	73.73	204.63
Total Current Liabilities	1,260	1,161	1,787	500.49	297.04	525.41
Long-Term Debt	1,718	1,705	1,869	2,039	1,266	1,307
Long-Term Leases	49.96	52.33	48.71	61.65	6.34	7.13
Other Long-Term Liabilities	1.42	0.84	1.94	2.35	7.95	0.77
Total Liabilities	3,030	2,920	3,707	2,604	1,578	1,845
Common Stock	4,295	4,295	4,295	4,295	4,295	4,295
Additional Paid-In Capital	829.5	829.5	835.41	849.05	855.12	830.21
Retained Earnings	127.94	351.19	597.61	1,238	944.84	1,123
Treasury Stock	-292.54	-292.54	-292.54	-292.54	-	-
Comprehensive Income & Other	41.55	49.49	38.94	34.62	53.79	68.03
Total Common Equity	5,002	5,233	5,475	6,124	6,149	6,316
Minority Interest	298.67	328.97	303.07	421.07	283.72	312.5
Shareholders' Equity	5,300	5,562	5,778	6,545	6,433	6,629
Total Liabilities & Equity	8,330	8,481	9,484	9,149	8,010	8,473
Total Debt	2,714	2,597	3,143	2,263	1,321	1,324
Net Cash (Debt)	-572.41	-139.56	-672.63	695.03	1,570	3,101
Net Cash Growth	-	-	-	-55.74%	-49.36%	-
Net Cash Per Share	-1.36	-0.33	-1.60	1.63	3.66	7.56
Filing Date Shares Outstanding	421.51	421.51	421.51	421.51	429.51	429.51
Total Common Shares Outstanding	421.51	421.51	421.51	421.51	429.51	429.51
Working Capital	2,087	2,449	2,912	3,991	3,499	4,521
Book Value Per Share	11.87	12.41	12.99	14.53	14.32	14.71
Tangible Book Value	4,971	5,198	5,423	6,056	6,063	6,215
Tangible Book Value Per Share	11.79	12.33	12.87	14.37	14.12	14.47
Land	14.36	14.36	14.36	14.36	14.36	14.36
Buildings	2,145	2,143	2,138	2,117	2,108	2,141
Machinery	2,326	2,319	2,332	2,255	1,999	2,529
Construction In Progress	1,464	1,379	1,029	1,100	1,032	317.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.